Teva Gets FDA Approval for Generic ADHD Drug

From Associated Press (February 14, 2013) NEW YORK -- Teva Pharmaceutical Industries Ltd. said Thursday that it received marketing approval for a generic version of Shire PLC’s Adderall XR, a treatment for attention deficit hyperactivity...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news